BR9812849A - Gel de dexametasona - Google Patents

Gel de dexametasona

Info

Publication number
BR9812849A
BR9812849A BR9812849-3A BR9812849A BR9812849A BR 9812849 A BR9812849 A BR 9812849A BR 9812849 A BR9812849 A BR 9812849A BR 9812849 A BR9812849 A BR 9812849A
Authority
BR
Brazil
Prior art keywords
gel
dexamethasone
preparation
dexamethasone gel
content
Prior art date
Application number
BR9812849-3A
Other languages
English (en)
Inventor
Guenther Bellmann
Gurdrun Claus-Herz
Christoph Kessler
Original Assignee
Mann Gerhard Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mann Gerhard Chem Pharm Fab filed Critical Mann Gerhard Chem Pharm Fab
Publication of BR9812849A publication Critical patent/BR9812849A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"GEL DE DEXAMETASONA''<D>. A invenção refere-se a um preparado oftalmológico com um teor de dexametasona como substância ativa, bem como eventualmente teores de substâncias aditivas e água, que é caracterizado por um ter de pelo menos uma substância farmacologicamente tolerável formadora de gel em uma quantidade suficiente para ajustar a viscosidade do preparado como gel.
BR9812849-3A 1997-10-06 1998-10-05 Gel de dexametasona BR9812849A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19744113A DE19744113A1 (de) 1997-10-06 1997-10-06 Dexamethason-Gel
PCT/EP1998/006339 WO1999017780A1 (de) 1997-10-06 1998-10-05 Dexamethason-gel

Publications (1)

Publication Number Publication Date
BR9812849A true BR9812849A (pt) 2000-08-08

Family

ID=7844743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812849-3A BR9812849A (pt) 1997-10-06 1998-10-05 Gel de dexametasona

Country Status (17)

Country Link
EP (1) EP1021192B1 (pt)
JP (1) JP4156793B2 (pt)
KR (1) KR100392481B1 (pt)
CN (1) CN1142782C (pt)
AR (1) AR017170A1 (pt)
AT (1) ATE230601T1 (pt)
BR (1) BR9812849A (pt)
CA (1) CA2300806C (pt)
DE (2) DE19744113A1 (pt)
DK (1) DK1021192T3 (pt)
ES (1) ES2191352T3 (pt)
HU (1) HU224986B1 (pt)
IL (1) IL135001A0 (pt)
MX (1) MXPA00003363A (pt)
PL (1) PL189727B1 (pt)
WO (1) WO1999017780A1 (pt)
ZA (1) ZA989066B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
CN101190177B (zh) * 2006-11-24 2010-09-01 上海医药工业研究院 醋酸地塞米松局部成膜凝胶组合物及其应用
US20150190407A1 (en) * 2014-01-07 2015-07-09 Insite Vision Incorporated Methods for treatment of postoperative inflammation with reduced intraocular pressure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212392C3 (de) * 1972-03-15 1981-03-19 Avicon Inc., Fort Worth, Tex. Verwendung von mikrokristallinem Collagen zur Herstellung eines wäßrigen pharmazeutischen Mittels für die topische Anwendung am Auge
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
EP0028110B1 (en) * 1979-10-26 1984-03-07 Smith and Nephew Associated Companies p.l.c. Autoclavable emulsions
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
WO1995005803A1 (en) * 1993-08-20 1995-03-02 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
DE4404990C1 (de) * 1994-02-17 1995-05-04 Mann Gerhard Chem Pharm Fab Verfahren zur Herstellung eines sterilen Prednisolongels
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
MXPA00003363A (es) 2007-12-07
JP4156793B2 (ja) 2008-09-24
ATE230601T1 (de) 2003-01-15
PL341026A1 (en) 2001-03-26
ZA989066B (en) 1999-06-15
WO1999017780A1 (de) 1999-04-15
CN1266369A (zh) 2000-09-13
IL135001A0 (en) 2001-05-20
HUP0003796A3 (en) 2001-05-28
EP1021192A1 (de) 2000-07-26
PL189727B1 (pl) 2005-09-30
WO1999017780A8 (de) 2000-01-27
HU224986B1 (en) 2006-05-29
JP2001518510A (ja) 2001-10-16
KR100392481B1 (ko) 2003-07-23
AR017170A1 (es) 2001-08-22
CA2300806C (en) 2004-02-03
ES2191352T3 (es) 2003-09-01
CN1142782C (zh) 2004-03-24
DE19744113A1 (de) 1999-04-15
EP1021192B1 (de) 2003-01-08
HK1030748A1 (en) 2001-05-18
CA2300806A1 (en) 1999-04-15
HUP0003796A2 (hu) 2001-04-28
DE59806884D1 (en) 2003-02-13
DK1021192T3 (da) 2003-05-05
KR20010030939A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
AR109995A2 (es) Método para inhibir la resorción ósea
BR0016341A (pt) Fórmula para bebês, processo para preparar um hidrolisado protéico, hidrolisado protéico, e, uso de um hidrolisado protéico
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
BR9815340A (pt) Utilização de pelo menos um ativador dos receptores de tipo ppar-y.
PT83471B (pt) Processo para a preparacao de uma composicao farmaceutica do tipo que passa por uma fase de transicao liquido-gel, contendo um polissacarideo
BRPI0417072B8 (pt) &#34;uso de antagonista de interleucina-6 (il-6)&#34;.
BR9811948A (pt) Secretores de hormÈnio do crescimento
BR9611362A (pt) Composicões detergentes
PT1100516E (pt) Extratos de matricaria (tanacetum parthenium) contra doencas inflamatorias
ES2151593T3 (es) Androstanos y pregnanos para modulacion alosterica del receptor de gaba.
BRPI0407757A (pt) derivados de benzamida tetracìclica e métodos de uso dos mesmos
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
BR9903211A (pt) Composição e utilização de um poliuretano associativo
PT902789E (pt) Derivados de androsteno
PE61196A1 (es) Aceite base para fluidos de penetracion de pozos
TR199802394A2 (xx) Proteinleri stabilize etmek i�in geli�tirilmi� proses.
BR0214810A (pt) Combinação de um inibidor de il-1/18 com um inibidor de tnf para o tratamento de inflamação
BR9812718A (pt) Uso de pelo menos 0,5%, em peso, de água como um aditivo em uma composição de vaporizador para cabelo, e, composição de vaporizador para cabelo
BR112021024233A2 (pt) Implante para fixar um tendão ou um ligamento a um tecido duro compreendendo um eixo, primeiros pilares para entrar em contato com um tecido duro, e segundos pilares para entrar em contato com um tendão ou um ligamento
PT817625E (pt) Composicoes para o tratamento de pele fotodanificada, compreendendo um antagonista de rar-alfa e um retinoide multi-selectivo
BRPI0514074A (pt) aperfeiçoamentos em composições em bloco para lavatório
AR004129A1 (es) Nuevos agentes glicomimeticos como antagonistas de selectinas y medicamentos que actuan inhibiendo las inflamaciones.
ES2147453T3 (es) Antagonistas de adenosina, procedimiento para su preparacion y su uso como medicamentos.
DE69923832D1 (de) Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
BR0109139A (pt) Composições farmacêuticas incluindo alginatos

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time